Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

DaVita HealthCare Partners ( DVA) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.6%. By the end of trading, DaVita HealthCare Partners rose $1.81 (1.4%) to $129.41 on average volume. Throughout the day, 777,745 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 783,200 shares. The stock ranged in a price between $126.21-$129.77 after having opened the day at $126.44 as compared to the previous trading day's close of $127.60. Other companies within the Health Services industry that increased today were: CardioNet ( BEAT), up 55.5%, Catamaran ( CTRX), up 10.9%, Electromed ( ELMD), up 9.3% and Luminex Corporation ( LMNX), up 6.1%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $13.4 billion and is part of the health care sector. The company has a P/E ratio of 30.3, above the S&P 500 P/E ratio of 17.7. Shares are up 14.4% year to date as of the close of trading on Monday. Currently there are 9 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Symmetry Medical ( SMA), down 14.9%, GenMark Diagnostics ( GNMK), down 12.9%, Baxano Surgical ( BAXS), down 9.9% and SunLink Health Systems ( SSY), down 8.4% , were all laggards within the health services industry with Intuitive Surgical ( ISRG) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.